| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/28/1993 | CA2109816A1 Novel amidoalkyl- and imidoalkyl-piperazines |
| 10/27/1993 | EP0567433A1 Orally-ingestible nutrition compositions having improved palatability |
| 10/27/1993 | EP0567431A1 Apparatus for removing components from solutions |
| 10/27/1993 | EP0567353A1 Use of 1-alpha,25-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis |
| 10/27/1993 | EP0567352A1 Use of 1-alpha,24(R)-dihydroxy-22(E)-dehydro-vitamin D3 for the manufacture of a medicament for the treatment of osteoporosis |
| 10/27/1993 | EP0567324A1 Medicaments for treating gar-transformylase-dependent tumors |
| 10/27/1993 | EP0567271A2 Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses |
| 10/27/1993 | EP0567251A1 Treatment of neurodegenerative diseases |
| 10/27/1993 | EP0567250A1 Treatment of neurodegenerative diseases |
| 10/27/1993 | EP0567223A1 Glutamic acid derivatives as antineoplastic agents |
| 10/27/1993 | EP0567216A1 Composition comprising omega-3 fatty acid source and glutathione stimulator for the treatment of immunedisorders and viral infections |
| 10/27/1993 | EP0567205A1 Use of opiate antagonists in the manufacture of agents for the diagnosis and therapy of hypothalamic function disorders |
| 10/27/1993 | EP0567201A2 Vehicles for oral administration of a specific pharmaceutically active acid labile substance |
| 10/27/1993 | EP0567162A1 Medicaments for the treatment of toxoplasmosis |
| 10/27/1993 | EP0567107A1 Quinoline and quinazoline derivatives for treating arthritis |
| 10/27/1993 | EP0567094A2 Hydrazoadenosines |
| 10/27/1993 | EP0567031A1 Regional chemotherapy with 4-hydroperoxycyclophosphamide |
| 10/27/1993 | EP0567026A1 4,1-Benzoxazepin derivatives as squalene synthase inhibitors and their use in the treatment of hypercholesteremia and as fungicides |
| 10/27/1993 | EP0566979A1 Hair lotion and hair treatment process for reducing hair loss and promoting hair growth |
| 10/27/1993 | EP0566971A1 Use of L-carnitine for the treatment of shock |
| 10/27/1993 | EP0566919A1 2,4-dioxoimidazoline derivatives |
| 10/27/1993 | EP0566732A1 Adeno-associated virus-2 basal vectors |
| 10/27/1993 | EP0566709A1 Composition comprising a tramadol compound and acetaminophen, and its use |
| 10/27/1993 | EP0566698A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 10/27/1993 | EP0566666A1 Novel glucohydrolase inhibitors useful as antidiabetic agents |
| 10/27/1993 | EP0566638A1 Flavor stable zinc acetate compositions for oral absorption |
| 10/27/1993 | EP0566593A1 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents |
| 10/27/1993 | EP0566589A1 N-alkyl quinuclidinium salts as substance p antagonists |
| 10/27/1993 | EP0566567A1 Antihypertensive benzopyran derivatives |
| 10/27/1993 | EP0566566A1 Compositions and methods for alleviating menopausal symptoms. |
| 10/27/1993 | EP0504180B1 Glycyl-p-amino-pyridine for the treatment of senile dementia states |
| 10/27/1993 | EP0479874B1 Use of norverapamil and norgallopamil as anti-arteriosclerosis drugs |
| 10/27/1993 | EP0425659B1 SUSTAINED RELEASE PHARMACEUTICAL PREPARATIONS HAVING pH CONTROLLED MEMBRANE COATINGS |
| 10/27/1993 | EP0398893B1 Preparation for dental treatment and method for production of the preparation |
| 10/27/1993 | EP0329656B1 Active principle isolated from shark tissues |
| 10/27/1993 | EP0191824B1 Encapsulation of antineoplastic agents in liposomes |
| 10/27/1993 | EP0190315B1 Dehydrated liposomes |
| 10/27/1993 | CN1077741A Carrot beer and its production process |
| 10/27/1993 | CN1077716A Antiviral peptides |
| 10/27/1993 | CN1077713A Pyrimidine derivatives and a process for production thereof |
| 10/27/1993 | CN1077711A Cycloalkyl-and heterocyclyl-substituted imidazolylpropenoic acid derivatives |
| 10/27/1993 | CN1077710A Sulphonylbenzyl-substituted imidazoles |
| 10/27/1993 | CN1077629A Polynucleotide nutrient product and its preparing process |
| 10/27/1993 | CN1077628A Tablet dissolved slowly in mouth and made of carotene microcapsule |
| 10/27/1993 | CN1022570C Process for preparing antiviral compounds |
| 10/27/1993 | CN1022569C Method for mfg. of tylosin and 10,11,12,13-tetrahydro-tylosin derivs. |
| 10/27/1993 | CN1022566C Process for preparation of substituted 1-piperidylalkylene-pyridopyrimidone or thiazolpyrimidone |
| 10/27/1993 | CN1022565C Process for preparing piperazinylalkyl-3(2H)-pyridazinones |
| 10/27/1993 | CN1022564C Anti high cholesterol blood tetrazole compound intermediate product and its preparing method |
| 10/26/1993 | US5256824 Substituted-amine compound and a process for the preparation thereof |
| 10/26/1993 | US5256820 Anticarcinogenic agents |
| 10/26/1993 | US5256814 Anticonvulsant, analgesic, cognition activator |
| 10/26/1993 | US5256789 Antiinflammatory hydroxamic acids and N-hydroxyureas |
| 10/26/1993 | US5256701 Disinfectant composition |
| 10/26/1993 | US5256700 Carnosic acid obtention and uses |
| 10/26/1993 | US5256699 Dispersible tablet formulation of diclofenac acid free base |
| 10/26/1993 | US5256698 Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine derivatives |
| 10/26/1993 | US5256697 Covalently linked pyruvyl-amino compound |
| 10/26/1993 | US5256696 Increase contraction of cardiac muscle |
| 10/26/1993 | US5256694 Diarylacetylenes, their preparation and their use |
| 10/26/1993 | US5256690 Administering 2-phenyl-1,3-propanediol dicarbamate |
| 10/26/1993 | US5256688 Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion |
| 10/26/1993 | US5256687 Synergistic mixture of angiotensin converting enzyme inhibitor and loop diuretic |
| 10/26/1993 | US5256684 Methods and compositions for the treatment of gastrointestinal disorders |
| 10/26/1993 | US5256682 Anxiolytic agents |
| 10/26/1993 | US5256676 3-hydroxy-pyridin-4-ones useful for treating parasitic infections |
| 10/26/1993 | US5256671 A prodrug as tachykinin antagonists for treating headaches, pain or inflammation |
| 10/26/1993 | US5256669 Methods and compositions for treating acute or chronic pain and drug addiction |
| 10/26/1993 | US5256668 Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus |
| 10/26/1993 | US5256667 Quinazolinones and pyridopyrimidinones |
| 10/26/1993 | US5256664 Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones |
| 10/26/1993 | US5256661 Substituted 2-aminotetralins and pharmaceutical use |
| 10/26/1993 | US5256660 Treating acidosis by administering aqueous buffer solution containing N-substituted aminosulfonic acid and sodium salt of different N-substituted aminosulfonic acid |
| 10/26/1993 | US5256654 Treating hypertension, congestive heart failure |
| 10/26/1993 | US5256652 Topical compositions and methods for treatment of male impotence |
| 10/26/1993 | US5256646 Antiviral antibiotic BU-4224V |
| 10/26/1993 | US5256631 Substituted 1,2,4-triazinediones, and their use |
| 10/26/1993 | US5256421 Hormone preparation and method |
| 10/26/1993 | US5256408 Aminosteroids for ophthalmic use |
| 10/26/1993 | US5256406 Treatment of hair loss and dermatological problems |
| 10/26/1993 | US5256398 Mixture of adenosine, or an adenosine antagonist, with an adenosine receptor |
| 10/26/1993 | US5256396 Topical composition |
| 10/26/1993 | US5256391 Method for synthesizing microporous crystalline material |
| 10/26/1993 | CA2033975C Use of .beta.-receptor blocking agents |
| 10/26/1993 | CA1323628C Fluoro-substituted epipodophyllotoxin glucosides |
| 10/26/1993 | CA1323578C Single-phase composition containing a perfluorinated oil and one or more surfactant(s), useful as an excipient for cosmetic and dermatologic formulations, as well as for biomedical applications |
| 10/26/1993 | CA1323577C Emulsified external treatment composition containing diclofenac sodium |
| 10/26/1993 | CA1323576C Long acting diclofenac sodium preparation |
| 10/26/1993 | CA1323575C Use of bezafibrate for treating diabetes |
| 10/26/1993 | CA1323574C Treating herpes viral infections |
| 10/26/1993 | CA1323573C Use of 2, 4-monofufurylidene-sorbitol and its tetraalkyl derivatives in cosmetics and dermatology |
| 10/26/1993 | CA1323572C Doxazosin as an anti-atherosclerosis agent |
| 10/26/1993 | CA1323565C Method and agents for removing advanced glycosylation endproducts |
| 10/26/1993 | CA1323562C Dermal treatment of worm diseases in cats with praziquantel |
| 10/25/1993 | CA2094774A1 Pharmaceutical composition containing quinoline and quinazoline derivatives and novel compounds therefor |
| 10/25/1993 | CA2094665A1 Apparatus for removing components from solutions |
| 10/25/1993 | CA2094548A1 Aminoalcohols-n-acylderivatives as therapeutical agents against the neurogenic endoneural oedema developing at the peripheral nerve |
| 10/24/1993 | CA2094687A1 Method of treating gar-transformylase-dependent tumors |
| 10/24/1993 | CA2094465A1 Cycloalkane derivatives |
| 10/24/1993 | CA2094311A1 Method of reducing or preventing toxicity associated with antiretroviral therapy |